{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:29Z","timestamp":1760189129293},"reference-count":16,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":8606,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1985,10]]},"abstract":"<jats:p>The growth pattern of bone marrow cells in agar cultures was studied in 48 patients with acute myeloblasts leukaemia or myelodysplasia, secondary to cytoreductive treatment, and compared to other laboratory findings. At diagnosis the status of the patients was: acute myeloblastic leukaemia (AML) in 9, acute myeloproliferative syndrome (AMS) in 13 and preleukaemic syndrome (PL) in 26 patients. 20 of the 39 patients with AMS and PL developed acute leukaemia, 15 of them within 1 year. 15 died of complications to cytopenia and only 4 are still alive and without leukaemia, observed from 8 to 55 months.<\/jats:p><jats:p>Progression to AML was predicted from the agar cultures by increased cluster growth. Among 18 patients with increased cluster growth at diagnosis 14 subsequently developed AML. Among 21 patients with normal or decreased cluster growth at diagnosis 6 patients developed AML, but after conversion of the growth pattern to increased cluster growth. In 2 patients the increased cluster growth disappeared spontaneously and the patients are long\u2010term leukaemia\u2010free survivors.<\/jats:p><jats:p>Colony growth pattern, conversely, was not related to leukaemic progression. Only 1 patient had normal growth pattern at diagnosis with respect to both clusters and colonies. Survival was short, with a median of about 7 months, unrelated to growth pattern and leukaemic progression.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1985.tb02266.x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T22:24:45Z","timestamp":1280960685000},"page":"423-429","source":"Crossref","is-referenced-by-count":2,"title":["Predictive value of bone marrow cultures in 48 patients with acute myeloblasts leukaemia or myelodysplasia both secondary to treatment of other malignant diseases"],"prefix":"10.1111","volume":"35","author":[{"given":"B. Thing","family":"Mortensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pedersen\u2010Bjergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Tinggaard","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Westrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ersb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Philip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. I.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood.V61.6.1035.1035","article-title":"The smoldering myeloid leukemic states: Clinical and biological features","volume":"61","author":"Greenberg PL.","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810401)47:7<1867::AID-CNCR2820470725>3.0.CO;2-S"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V57.4.712.712","article-title":"Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing","volume":"57","author":"Pedersen\u2010Bjergaard J.","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V58.4.759.759"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840801)54:3<452::AID-CNCR2820540313>3.0.CO;2-9"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830701)52:1<83::AID-CNCR2820520117>3.0.CO;2-9"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(79)90007-9"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1200\/JCO.1983.1.10.627","article-title":"Marrow cytogenetic and cell\u2010culture analyses of the myelodysplastic syndromes: Insights to pathophysiology and prognosis","volume":"1","author":"Gold EJ","year":"1983","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92357-7"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90450-9"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1040760111"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1976.43"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-67470-9_20"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-67470-9_28"},{"key":"e_1_2_1_17_2","first-page":"601","article-title":"Effect of chemotherapy for the dysmyelopoietic syndrome","volume":"65","author":"Armitage JO","year":"1981","journal-title":"Cancer Treat Rep"}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1985.tb02266.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1985.tb02266.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T20:24:16Z","timestamp":1697833456000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1985.tb02266.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985,10]]}},"alternative-id":["10.1111\/j.1600-0609.1985.tb02266.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1985.tb02266.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1985,10]]}}}